BCR-ABL Quantitative with p210 breakpoint in Dulmi-nadiha
Test • Include 1 Tests
Measures the amount of the BCR ABL gene in the blood to monitor treatment effectiveness in patients with CML.- Measures the amount of the BCR ABL gene in the blood to monitor treatment effectiveness in patients with CML.